REQUEST A DEMO
Total
USD $0.00
Search more companies

Humax Pharmaceutical S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Humax Pharmaceutical S.A. Profile Updated: October 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Humax Pharmaceutical S.A. is an enterprise located in Colombia, with the main office in La Estrella. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on February 11, 2005. 295 (2024) employees currently work for Humax Pharmaceutical S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 21.88% in 2023. A growth of 24.05% was recorded in its total assets. Humax Pharmaceutical S.A.’s net profit margin decreased by 4.13% in 2023.

Headquarters
Cl 97B Sur # 50 95
La Estrella; Antioquia;

Contact Details: Purchase the Humax Pharmaceutical S.A. report to view the information.

Website: http://www.humax.com.co

Basic Information
Total Employees:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Outstanding Shares:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Humax Pharmaceutical S.A. report to view the information.
Incorporation Date:
February 11, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Humax Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
21.88%
Total operating revenue
20.48%
Operating profit (EBIT)
-96.76%
EBITDA
-92.39%
Net Profit (Loss) for the Period
-54.42%
Total assets
24.05%
Total equity
50.05%
Operating Profit Margin (ROS)
-16.89%
Net Profit Margin
-4.13%
Return on Equity (ROE)
-6.57%
Debt to Equity Ratio
-1.85%
Quick Ratio
1.03%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?